A drug with the SMILES CCC(C)[C@H](NC(=O)[C@@H]1Cc2c([nH]c3ccccc23)C2c3ccccc3C(=O)N21)C(=O)N1CCC[C@@H]1C(=O)O has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.994\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CCC(C)[C@H](NC(=O)[C@@H]1Cc2c([nH]c3ccccc23)C2c3ccccc3C(=O)N21)C(=O)N1CCC[C@@H]1C(=O)O
CCC(C)[C@H](NC(=O)[C@@H]1Cc2c([nH]c3ccccc23)C2c3ccccc3C(=O)N21)C(=O)N1CCC[C@@H]1C(=O)O
(2R)-1-[(2S)-3-methyl-2-[[(11S)-9-oxo-10,20-diazapentacyclo[11.7.0.02,10.03,8.014,19]icosa-1(13),3,5,7,14,16,18-heptaene-11-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylic acid